SELECT Trial Semaglutide and Cardiovascular Outcomes (NEJM, 2023): 20% reduction in major adverse cardiovascular events with Wegovy in overweight/obesity
You're into one right now of some 20,000 participants to see whether not just people with prior heart disease, but people without known heart disease to see whether or not this will have an effect
Michael Bass, a board-certified gastroenterologist, highlights that if youre experiencing a significant change from your normal routinefor example, going from daily bowel movements to only once every few days, accompanied by discomfort or strainingits a sign that constipation is occurring
Semaglutides action, by comparison, relies solely on GLP-1 receptors 36
So what else can cause joint pain if not Ozempic